High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia. [electronic resource]
Producer: 20030717Description: 47-53 p. digitalISSN:- 1466-4860
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Betamethasone -- administration & dosage
- Bone Marrow Diseases -- chemically induced
- Burkitt Lymphoma -- drug therapy
- Comorbidity
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Drug Carriers
- Female
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Infections -- etiology
- Leukemia, T-Cell -- drug therapy
- Life Tables
- Liposomes
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prospective Studies
- Remission Induction
- Safety
- Survival Analysis
- Topotecan -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.